CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Text triageother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05134636
NCT05134636N/ACompleted

Text-based Intervention to Minimize the Time Burden of Routine Cancer Care

Abramson Cancer Center at Penn Medicine·interventional·Posted Nov 26, 2021·Updated Mar 6, 2025

In Brief

A clinical study evaluating Text triage for Cancer and 3 related conditions. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The primary objective is to test whether a text-based e-triage can safely minimize the time associated with routine cancer care by identifying patients who can proceed directly to their immunotherapy infusion without a preceding in-person office assessment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedNov 26, 2021
Enrollment StartDec 6, 2021
Primary CompletionDec 12, 2022
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 4.6 years ago

Interventions

Text triageother

The e-triage will consist of 16 questions, modified from the validated NCI Pro-CTCAETM, which will be sent to patients via WaytoHealth©'s two-way texting system 96 hours prior to their scheduled immunotherapy infusion. Questions will pertain to common or emergent immune related adverse events as defined by the NCCN guidelines and two senior disease experts. Patients will be prompted via text to measure the presence and severity of symptoms over the week prior. A final question will be included to capture any additional symptoms patients wish to disclose.